ALLOVIR INC's ticker is ALVR and the CUSIP is 019818103. A total of 71 filers reported holding ALLOVIR INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $46,427 | -36.8% | 21,594 | 0.0% | 0.00% | – |
| Q2 2023 | $73,420 | -5.8% | 21,594 | +9.2% | 0.00% | – |
| Q1 2023 | $77,909 | +2.8% | 19,774 | +33.9% | 0.00% | – |
| Q4 2022 | $75,765 | -34.1% | 14,769 | +1.4% | 0.00% | – |
| Q3 2022 | $115,000 | +66.7% | 14,561 | -16.6% | 0.00% | – |
| Q2 2022 | $69,000 | -59.9% | 17,451 | -31.5% | 0.00% | – |
| Q1 2022 | $172,000 | -49.7% | 25,477 | -3.4% | 0.00% | – |
| Q4 2021 | $342,000 | -51.1% | 26,375 | -5.5% | 0.00% | – |
| Q3 2021 | $700,000 | +42.6% | 27,916 | +12.3% | 0.00% | – |
| Q2 2021 | $491,000 | -19.9% | 24,866 | -5.2% | 0.00% | – |
| Q1 2021 | $613,000 | -14.5% | 26,224 | +40.6% | 0.00% | – |
| Q4 2020 | $717,000 | +116.0% | 18,657 | +54.4% | 0.00% | – |
| Q3 2020 | $332,000 | – | 12,085 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Artal Group S.A. | 5,577,167 | $44,004,000 | 1.88% |
| GMT CAPITAL CORP | 2,758,846 | $21,767,000 | 1.35% |
| Regency Capital Management Inc.\DE | 75,010 | $592,000 | 0.73% |
| Redmile Group, LLC | 1,907,969 | $15,054,000 | 0.58% |
| Samsara BioCapital, LLC | 82,336 | $650,000 | 0.15% |
| Alkeon Capital Management | 4,923,104 | $38,843,000 | 0.13% |
| Woodline Partners LP | 1,087,093 | $8,577,000 | 0.12% |
| GSA CAPITAL PARTNERS LLP | 77,625 | $612,000 | 0.08% |
| CORNERCAP INVESTMENT COUNSEL INC | 44,987 | $355,000 | 0.07% |
| AMERICAN INTERNATIONAL GROUP, INC. | 1,143,634 | $9,023,000 | 0.07% |